In a filing, NovoCure Ltd revealed its Chief Operating Officer Paravasthu Mukund unloaded Company’s shares for reported $734.0 on Nov 02 ’24. In the deal valued at $16.69 per share,44 shares were sold. As a result of this transaction, Paravasthu Mukund now holds 3,459 shares worth roughly $57004.32.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Puri Michal Nath sold 810 shares, generating $12,792 in total proceeds. Upon selling the shares at $15.79, the Chief Human Resources Officer now owns 110,093 shares.
Before that, Leonard Frank X sold 598 shares. NovoCure Ltd shares valued at $9,531 were divested by the EVP, Pres., Novocure Oncology at a price of $15.94 per share. As a result of the transaction, Leonard Frank X now holds 161,236 shares, worth roughly $2.66 million.
H.C. Wainwright upgraded its NovoCure Ltd [NVCR] rating to a Buy from a a Neutral in a research note published on October 16, 2024; the price target was increased to $30 from $24. H.C. Wainwright also remained covering NVCR and has decreased its forecast on August 28, 2023 with a “Neutral” recommendation from previously “Buy” rating. Piper Sandler revised its rating on August 08, 2023. It rated NVCR as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of NVCR
On Tuesday, NovoCure Ltd [NASDAQ:NVCR] saw its stock jump 4.77% to $16.48. Over the last five days, the stock has lost -7.52%. NovoCure Ltd shares have risen nearly 10.38% since the year began. Nevertheless, the stocks have risen 33.23% over the past one year. While a 52-week high of $24.74 was reached on 05/20/24, a 52-week low of $11.29 was recorded on 04/23/24. SMA at 50 days reached $16.53, while 200 days put it at $17.10.
Levels Of Support And Resistance For NVCR Stock
The 24-hour chart illustrates a support level at 15.70, which if violated will result in even more drops to 14.93. On the upside, there is a resistance level at 16.90. A further resistance level may holdings at 17.33. The Relative Strength Index (RSI) on the 14-day chart is 48.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.79, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.34%. Stochastics %K at 28.20% indicates the stock is a holding.
How much short interest is there in NovoCure Ltd?
A steep rise in short interest was recorded in NovoCure Ltd stocks on 2024-10-31, growing by 0.47 million shares to a total of 5.96 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 5.49 million shares. There was a rise of 7.85%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 04, 2023 when SVB Securities began covering the stock and recommended ‘”an Outperform”‘ rating along with a $51 price target.
